US Patent Issued to UNIVERSITE CLAUDE BERNARD LYON 1, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), ECOLE NORMALE SUPERIEURE DE LYON, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), UNIVERSITE LAVAL on April 29 for "Diltiazem for use in the treatment of microbial infections" (French, Canadian Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,285,433, issued on April 29, was assigned to UNIVERSITE CLAUDE BERNARD LYON 1 (Villeurbanne, France), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (Paris), ECOLE NORMALE SUPERIEURE DE LYON (Lyons, France), INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (Paris) and UNIVERSITE LAVAL (Quebec, Canada).

"Diltiazem for use in the treatment of microbial infections" was invented by Manuel Rosa-Calatrava (Lyons, France), Olivier Terrier (Lyons, France), Claire Nicolas De Lamballerie (Ensues la Redonne, France), Guy Boivin (Quebec, Canada) and Mario Andres Pizzorno (Lyons, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present...